Fuzi reduced the proportion of Treg cells, decreased serum levels of cytokines and transforming growth factor (TGF)-β, and downregulated the expression of programmed death ligand-1 in mice, which suggests that Fuzi has immunomodulation properties to improve radiotherapy against lung cancer [51]. The gene discussed is TGFB1; the disease is lung cancer.